Who Owns INO?

Inovio Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$1.18

+0.03 (+2.61%)

Market Cap

$93.5M

Shares Outstanding

53,589,864

Institutional Holders

108

Total Inst. Value

$22.0M

% of Float Held

25.4%

QoQ Holder Change

+35

Institutional data as of Q1 2025

New Positions

23

Closed Positions

14

Increased

34

Decreased

25

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Deep Track Capital, LP$5.1M3,119,162
2BlackRock, Inc.$3.8M2,318,480
3VANGUARD GROUP INC$3.3M2,028,960
4BANK OF AMERICA CORP /DE/$2.1M1,304,987
5GEODE CAPITAL MANAGEMENT, LLC$1.4M846,803
6Stonepine Capital Management, LLC$845K518,331
7STATE STREET CORP$838K514,148
8NORTHERN TRUST CORP$759K465,778
9MORGAN STANLEY$461K284,643
10UBS Group AG$339K207,867

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold INO?

As of Q1 2025, 108 institutional investors report holding INO (Inovio Pharmaceuticals, Inc.) in their 13F filings.

What percentage of Inovio Pharmaceuticals, Inc. is owned by institutions?

Institutional investors hold approximately 25.4% of Inovio Pharmaceuticals, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most INO?

The largest institutional holder of INO is Deep Track Capital, LP with $5.1M in shares.

Are institutions buying or selling INO?

This quarter, 23 institutions opened new positions in INO and 14 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.